Mark Sheptoff Financial Planning LLC Sells 165 Shares of Colgate-Palmolive (NYSE:CL)

Mark Sheptoff Financial Planning LLC lowered its position in Colgate-Palmolive (NYSE:CLFree Report) by 2.0% in the 4th quarter, HoldingsChannel.com reports. The fund owned 8,264 shares of the company’s stock after selling 165 shares during the quarter. Mark Sheptoff Financial Planning LLC’s holdings in Colgate-Palmolive were worth $659,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently bought and sold shares of the company. Union Savings Bank increased its stake in shares of Colgate-Palmolive by 76.6% in the fourth quarter. Union Savings Bank now owns 309 shares of the company’s stock worth $25,000 after purchasing an additional 134 shares in the last quarter. Avion Wealth raised its holdings in Colgate-Palmolive by 78.1% during the fourth quarter. Avion Wealth now owns 399 shares of the company’s stock valued at $32,000 after acquiring an additional 175 shares during the period. Atlantic Edge Private Wealth Management LLC bought a new position in shares of Colgate-Palmolive in the fourth quarter worth about $32,000. McGlone Suttner Wealth Management Inc. purchased a new stake in shares of Colgate-Palmolive during the fourth quarter worth about $34,000. Finally, Kayne Anderson Rudnick Investment Management LLC raised its stake in Colgate-Palmolive by 142.0% during the 3rd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 496 shares of the company’s stock valued at $35,000 after purchasing an additional 291 shares during the period. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Trading Down 0.7 %

CL stock traded down $0.70 during trading on Thursday, reaching $94.06. 1,080,535 shares of the stock were exchanged, compared to its average volume of 4,563,947. The company has a current ratio of 1.06, a quick ratio of 0.70 and a debt-to-equity ratio of 13.21. The firm has a market capitalization of $77.17 billion, a price-to-earnings ratio of 29.91, a P/E/G ratio of 3.51 and a beta of 0.40. The business has a 50 day moving average price of $90.17 and a 200-day moving average price of $84.17. Colgate-Palmolive has a 1 year low of $67.62 and a 1 year high of $95.59.

Colgate-Palmolive (NYSE:CLGet Free Report) last posted its quarterly earnings data on Friday, April 26th. The company reported $0.86 earnings per share for the quarter, topping analysts’ consensus estimates of $0.82 by $0.04. The firm had revenue of $5.07 billion during the quarter, compared to analysts’ expectations of $4.96 billion. Colgate-Palmolive had a net margin of 13.22% and a return on equity of 485.40%. The firm’s quarterly revenue was up 6.2% on a year-over-year basis. During the same quarter last year, the company posted $0.73 EPS. On average, research analysts predict that Colgate-Palmolive will post 3.53 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, May 15th. Stockholders of record on Monday, April 22nd were paid a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.13%. The ex-dividend date was Friday, April 19th. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.48. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 63.29%.

Insider Buying and Selling

In related news, insider Sally Massey sold 12,226 shares of the business’s stock in a transaction on Thursday, May 9th. The shares were sold at an average price of $94.06, for a total transaction of $1,149,977.56. Following the completion of the transaction, the insider now owns 13,924 shares in the company, valued at $1,309,691.44. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In related news, insider Sally Massey sold 12,226 shares of the company’s stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $94.06, for a total value of $1,149,977.56. Following the completion of the transaction, the insider now directly owns 13,924 shares of the company’s stock, valued at $1,309,691.44. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider John W. Kooyman sold 3,497 shares of the firm’s stock in a transaction that occurred on Tuesday, May 7th. The stock was sold at an average price of $93.47, for a total transaction of $326,864.59. Following the sale, the insider now directly owns 3,181 shares in the company, valued at approximately $297,328.07. The disclosure for this sale can be found here. Insiders own 0.34% of the company’s stock.

Analysts Set New Price Targets

CL has been the topic of several recent analyst reports. Barclays lifted their price objective on shares of Colgate-Palmolive from $84.00 to $85.00 and gave the company an “equal weight” rating in a research report on Tuesday, April 30th. StockNews.com cut shares of Colgate-Palmolive from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, February 20th. Argus raised their price objective on Colgate-Palmolive from $97.00 to $107.00 and gave the company a “buy” rating in a research report on Wednesday, May 15th. Stifel Nicolaus boosted their target price on Colgate-Palmolive from $94.00 to $95.00 and gave the stock a “buy” rating in a research report on Monday, April 29th. Finally, Evercore ISI lifted their price objective on Colgate-Palmolive from $90.00 to $96.00 and gave the stock an “outperform” rating in a research note on Monday, April 8th. Three analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $92.35.

Check Out Our Latest Stock Report on Colgate-Palmolive

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Further Reading

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.